Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol premedication to reduce perioperative respiratory adverse events in children with congenital scoliosis
ChiCTR2300070934Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salbutamol in congenital scoliosis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Occurrence of perioperative respiratory adverse events. Planned start May 2023; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
congenital scoliosis
Beyond the preview
Go deeper on ChiCTR2300070934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070934.